ROBERT MULLER: Open Payments
NPI 1538377668 · MONTOURSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 75 payments from 17 companies in 2025. Trend: 2023 $1,166 · 2024 $1,266 · 2025 $1,512
Food & beverage: $1,496Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $266 |
| Novo Nordisk Inc | 12 | $216 |
| Lilly USA, LLC | 9 | $177 |
| ABBVIE INC. | 7 | $155 |
| Dexcom, Inc. | 5 | $119 |
| Exact Sciences Corporation | 5 | $116 |
| Amgen Inc. | 6 | $106 |
| Astellas Pharma US Inc | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: Ozempic, QULIPTA, JARDIANCE, Dexcom G6 Transmitter, BREZTRI, REPATHA, AIRSUPRA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
